Solutions · Pillar

Regenerative Medicine - Autologous Therapies

Autologous platelet-rich therapies, bone-marrow aspirate concentrate, and nanofat for tissue regeneration. All sourced from the patient - no donor or animal material.

Pillar Overview

OrganoGEN's Regenerative Medicine portfolio is fully autologous - every therapy is sourced from the patient's own blood, marrow, or adipose tissue. Vivostat® autologous fibrin sealant (Denmark), Endoret® PRGF Plasma Rich in Growth Factors (BTI, Spain - 500+ peer-reviewed publications across 25+ years), Marrow Cellution™ BMAC harvest (Aspire, USA), and Tulip® Nanofat adipose grafting (Tulip, USA - OrganoGEN is the Cyprus-exclusive distributor) cover orthopaedic, sports-medicine, and aesthetic indications. In Cyprus, regenerative therapies sit in the private-pay tier, outside GESY reimbursement.

Stem cell therapy in Cyprus: what OrganoGEN supplies

OrganoGEN is a medical-device distributor, not a clinic, and does not treat patients. The one cell-based therapy in the range is bone marrow aspirate concentrate (BMAC), harvested with the Marrow Cellution™ system: a concentrate of the patient's own bone marrow, containing mesenchymal cells and other progenitors, prepared in theatre during the same procedure, with no laboratory culture or expansion.

Endoret® PRGF and Vivostat® PRF are platelet-derived preparations. They deliver growth factors and contain no stem cells. Tulip® Nanofat is mechanically processed autologous fat. All of these are private-pay in Cyprus and are performed by the treating surgeon at a clinic. OrganoGEN supplies the device and supports the surgeon in theatre.

Does OrganoGEN offer stem cell therapy in Cyprus?

Not as a clinic. OrganoGEN distributes the Marrow Cellution™ system that surgeons in Cyprus use to harvest a patient's own bone marrow concentrate, which contains mesenchymal cells. The procedure is private-pay and is performed by a surgeon. Ask us for a referral to a surgeon trained on the system.